| scholarly article | Q13442814 |
| P2093 | author name string | Hao Wang | |
| Ye Cui | |||
| Robert F Padera | |||
| Gary Visner | |||
| Kaifeng Liu | |||
| Ivan O Rosas | |||
| Souheil El-Chemaly | |||
| Mark A Perrella | |||
| Hilary J Goldberg | |||
| Demet Toprak | |||
| Elie Abdelnour | |||
| Emmanuel D'Agostino | |||
| Gautam George | |||
| Maria E Monzon-Medina | |||
| Rosanna Malbran Forteza | |||
| P2860 | cites work | LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan | Q22008808 |
| Visualization of intrapulmonary lymph vessels in healthy and inflamed murine lung using CD90/Thy-1 as a marker | Q27317170 | ||
| Emerging roles of lymphatic endothelium in regulating adaptive immunity | Q27686792 | ||
| LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis | Q28207071 | ||
| Resolution of lung inflammation by CD44 | Q28506254 | ||
| Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium | Q28506923 | ||
| Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway | Q28576535 | ||
| Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms | Q30486123 | ||
| Central memory CD8+ T lymphocytes mediate lung allograft acceptance. | Q30573064 | ||
| Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule | Q33518439 | ||
| Lung transplantation. | Q33588873 | ||
| Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. | Q33731734 | ||
| Alloreactivity and apoptosis in graft rejection and transplantation tolerance. | Q34006909 | ||
| Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP. | Q34071823 | ||
| VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease | Q34117538 | ||
| Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation | Q34161479 | ||
| CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gram-negative pneumonia | Q34254524 | ||
| Hyaluronan and layilin mediate loss of airway epithelial barrier function induced by cigarette smoke by decreasing E-cadherin | Q34304839 | ||
| Molecular characterization of lymphatic endothelial cells. | Q34415420 | ||
| Lung structure phenotype variation in inbred mouse strains revealed through in vivo micro-CT imaging | Q34426864 | ||
| Regulation of lung injury and repair by Toll-like receptors and hyaluronan | Q34462186 | ||
| Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. | Q34544391 | ||
| The role of hyaluronan degradation products as innate alloimmune agonists. | Q34574846 | ||
| Markers for microscopic imaging of lymphangiogenesis and angiogenesis | Q34656435 | ||
| Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection | Q34728157 | ||
| Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection | Q35015782 | ||
| Clinicopathological correlation analysis of (lymph) angiogenesis and corneal graft rejection | Q35089344 | ||
| Impaired lymphatic contraction associated with immunosuppression | Q35558779 | ||
| Cardiac lymphatics are heterogeneous in origin and respond to injury. | Q35690246 | ||
| Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects | Q35791536 | ||
| Hyaluronan | Q36001372 | ||
| Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis | Q36173570 | ||
| Indoleamine 2,3-dioxygenase and metabolites protect murine lung allografts and impair the calcium mobilization of T cells | Q36369985 | ||
| Lymphangiogenic gene therapy with minimal blood vascular side effects | Q36371262 | ||
| Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation | Q36497556 | ||
| Is defective lymphatic drainage a trigger for lymphoid neogenesis? | Q36571605 | ||
| Hyaluronan in tissue injury and repair | Q36824173 | ||
| Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. | Q36907900 | ||
| The role of hyaluronan synthase 3 in ventilator-induced lung injury. | Q37282731 | ||
| Steroids and β2-agonists regulate hyaluronan metabolism in asthmatic airway smooth muscle cells | Q84735243 | ||
| Inhibition of the purinergic pathway prolongs mouse lung allograft survival | Q87503781 | ||
| Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology | Q37359724 | ||
| Acute rejection and humoral sensitization in lung transplant recipients | Q37365017 | ||
| Lymphatic vessels and tertiary lymphoid organs | Q37602241 | ||
| Inflammation-associated lymphangiogenesis: a double-edged sword? | Q37609665 | ||
| Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity | Q37688479 | ||
| Regulation of non-infectious lung injury, inflammation, and repair by the extracellular matrix glycosaminoglycan hyaluronan. | Q37699092 | ||
| The lymphatic vasculature in disease | Q37953774 | ||
| Small animal models of experimental obliterative bronchiolitis | Q38080015 | ||
| Lymphangiogenic factors, mechanisms, and applications | Q38192927 | ||
| VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study | Q39001886 | ||
| Lymphatic injury and regeneration in cardiac allografts | Q39551094 | ||
| Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism | Q39984665 | ||
| Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats | Q40346584 | ||
| Hyaluronan‐binding proteins in development, tissue homeostasis, and disease | Q40490752 | ||
| Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation. | Q40774230 | ||
| Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy | Q40872737 | ||
| A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities | Q41050928 | ||
| Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1 | Q41936261 | ||
| Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection | Q42246110 | ||
| The lymphatic vasculature revisited | Q42427746 | ||
| Lung transplantation in the United States, 1999-2008. | Q43602668 | ||
| Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. | Q45877874 | ||
| The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis | Q46535751 | ||
| First year changes of myocardial lymphatic endothelial markers in heart transplant recipients | Q46913389 | ||
| An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution | Q47374331 | ||
| Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function | Q47405553 | ||
| Left-sided mouse intubation: description and evaluation. | Q50447793 | ||
| Angiogenic role of LYVE-1-positive macrophages in adipose tissue. | Q51995490 | ||
| Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphang | Q52025802 | ||
| Anastomotic pitfalls in lung transplantation. | Q52514385 | ||
| Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis. | Q52624854 | ||
| Lymph angiogenesis after lung transplantation and relation to acute organ rejection in humans. | Q53170738 | ||
| Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. | Q54485417 | ||
| Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase | Q71613841 | ||
| Detection of canine allograft lung rejection by pulmonary lymphoscintigraphy | Q72083834 | ||
| Reestablishment of lymphatic drainage after canine lung transplantation | Q72804887 | ||
| Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy | Q73194238 | ||
| Recipient T cells mediate reperfusion injury after lung transplantation in the rat | Q79274143 | ||
| Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies | Q79731731 | ||
| Lymphatics and the heart: the importance of visceral lymphatic function in health and disease | Q80349538 | ||
| Surgical technique of experimental lung transplantation in rabbits | Q81570663 | ||
| Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome | Q81923118 | ||
| Influence of route of administration and liposomal encapsulation on blood and lymph node exposure to the protein VEGF-C156S | Q82222721 | ||
| A mouse model of orthotopic, single-lung transplantation | Q83276662 | ||
| Lymph node-derived lymphatic endothelial cells express functional costimulatory molecules and impair dendritic cell-induced allogenic T-cell proliferation | Q83766820 | ||
| Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1 | Q84486812 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphangiogenesis | Q6708231 |
| P304 | page(s) | 4255-4268 | |
| P577 | publication date | 2015-10-20 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection | |
| P478 | volume | 125 |
| Q42911358 | A Critical Role for Airway Microvessels in Lung Transplantation |
| Q39006011 | Airway remodelling in the transplanted lung |
| Q38845953 | Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses |
| Q42126369 | Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction |
| Q92757529 | Connective tissue growth factor is correlated with peritoneal lymphangiogenesis |
| Q38771577 | Danger signals in regulating the immune response to solid organ transplantation |
| Q90284214 | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease |
| Q47940254 | Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges. |
| Q98182927 | FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake |
| Q64065009 | Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways |
| Q40366865 | HA-ving lymphatics improves lung transplantation |
| Q92948891 | Hyaluronan and LYVE-1 and allograft function in lung transplantation recipients |
| Q50150200 | Hyaluronan interactions with innate immunity in lung biology. |
| Q91644213 | Imaging Lymphatics in Mouse Lungs |
| Q58123958 | Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury |
| Q33860126 | Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin |
| Q64261966 | Inhibition of B cell–dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation |
| Q50273163 | Lymphangiogenesis in rat asthma model |
| Q39263241 | Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung? |
| Q49847182 | Lymphatic Vessels: The Next Frontier in Lung Transplant |
| Q92843566 | Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage |
| Q39012703 | Mechanisms of graft rejection after lung transplantation |
| Q36893931 | Microvascular injury after lung transplantation |
| Q30352802 | Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop. |
| Q59470382 | Perioperative management of esophagectomy in a patient who previously underwent bilateral lung transplantation |
| Q50419857 | Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. |
| Q98772124 | Regional Lymphatic Inclusion in Orthotopic Hindlimb Transplantation: Establishment and Assessment of Feasibility in a Rodent Model |
| Q58710420 | Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis |
| Q41340368 | The Lymphatic System: Integral Roles in Immunity |
| Q36902371 | The role of hyaluronan in the pathobiology and treatment of respiratory disease |
| Q37707913 | Vitamin D inhibits lymphangiogenesis through VDR-dependent mechanisms |
Search more.